a medicinal product on the basis of a aryloxypropanolamin for selective antagonisering of 5 - 5-ht1 receptors

摘要

This invention provides a method of selectively antagonizing the 5-HT1 receptor in mammals by administering aryloxypropanolamines. Novel aryloxypropanolamines are also claimed.